Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2026-01-06 @ 9:03 PM
Study NCT ID:
NCT00091832
Status:
COMPLETED
Last Update Posted:
2014-01-28
First Post:
2004-09-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer
Sponsor:
Amgen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
20040113
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None